Δαμιανάκη Αθηνά

Εργαστηριακή μελέτη νοσημάτων, κυρίως αιματολογικών

1.Myeloid-derived suppressor cells exhibit distinct characteristics in bone marrow and blood of individuals with diffuse large B-cell lymphoma. Efstratiou P, Damianaki A, Kavidopoulou A, Ioannidou P, Markaki E, Skianis IM, Tsagliotis E, Kaliafentaki V, Mattheakakis A, Ximeri M, Manouras E, Lavigne M, Verginis P, Kalpadakis C. Front Med (Lausanne). 2025 Jan 29;11:1515097. doi: 10.3389/fmed.2024.1515097. eCollection 2024. PMID: 39944818 .
2. Necroptotic and Apoptotic Pathways in Sepsis: A Comparative Analysis of Pediatric and Adult ICU Patients.Briassoulis G, Tzermia K, Bastaki K, Miliaraki M, Briassoulis P, Damianaki A, Kondili E, Ilia S.Biomedicines. 2025 Jul 17;13(7):1747. doi: 10.3390/biomedicines13071747.PMID: 40722817 3. “Increased proportion and altered properties of intermediate monocytes in the peripheral blood of patients with lower risk Myelodysplastic Syndrome”. Velegraki M, Papakonstantinou N, Kalaitzaki L, Ntoufa S, Laidou S,Tsagiopoulou M, Bizymi N, Damianaki A, Mavroudi I, Pontikoglou C, Papadaki HA. Blood Cells Mol Dis. 2021 Feb;86:102507,doi:10.1016/j.bcmd.2020.102507.Epub2020Sep28. PMID:33032166. 4. “Altered Monocyte Subsets in Patients with Chronic Idiopathic Neutropenia”. Bizymi N, Velegraki M, Damianaki A, Koutala H, Papadaki HA. J Clin Immunol. 2019Nov;39(8):852-854. doi: 10.1007/s10875-019-00694-5. Epub 2019 Oct 27. PMID:31655960; PMCID: PMC6863791.
5. ’’ Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton’s jelly and bone marrow-derived mesenchymal stem cells’’.Batsali Ak, Pontikoglou C, Koutroulakis D, Pavlaki Ki, Damianaki A, Mavroudi I, Alpantaki K, Kouvidi E, Kontakis G, Papadaki Ha.Stem Cell Res Ther. 2017 Apr 26;8(1):102. doi: 10.1186/s13287-017-0555-9. 6. Immunoglobulin and B-cell disturbances in patients with chronic idiopathic neutropenia. Mavroudi I, Eliopoulos Ag, Pontikoglou C, Pyrovolaki K, Damianaki A, Koutala H, Zervou Mi, Ximeri M, Mastrodemou S, Kanellou P, Goulielmos Gn, Papadaki Ha. Clin Immunol. 2017 Jul 18;183:75-81. doi: 10.1016/j.clim.2017.07.009. [Epub ahead of print] 7. Minor populations of paroxysmal nocturnal hemoglobinuria-type cells in patients with chronic idiopathic neutropenia.’’ Damianaki A, Stagakis E, Mavroudi I, Spanoudakis M, Koutala H, Papadogiannis F, Kanellou P, Pontikoglou C, Papadaki Ha Eur J Haematol. 2016 Dec;97(6):538-546. doi: 10.1111/ejh.12766. Epub 2016 May 25.
8. “Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway”. Pavlaki Ki, Pontikoglou Cg, Demetriadou A, Batsali Ak, Damianaki A, Simantirakis E, Kontakis M, Galanopoulos A, Kotsianidis I, Kastrinaki Mc, Papadaki Ha. Stem Cells Dev. 2014:15;23(14):1568-81.
9. Lymphopenia in patients with chronic idiopathic neutropenia is associated with decreased number of T-lymphocytes containing T-cell receptor excision circles. Gemetzi C, Mavroudi I, Koutala H, Velegraki M, Choulaki C, Damianaki A, Pontikoglou C, Papadaki HA. Eur J Haematol. 2012 Mar;88(3):210-23. Doi: 10.1111/j.1600-0609.2011.01722.x. Epub 2011 Nov 24.PMID:22092365.
10. Mesenchymal stem cells contribute to the abnormal bone marrow microenvironment in patients with chronic idiopathic neutropenia by overproduction of transforming growth factor-β1 . Stavroulaki E, Kastrinaki MC, Pontikoglou C, Eliopoulos D, Damianaki A, Mavroudi I, Pyrovolaki K, Katonis P, Papadaki HA. Stem Cells Dev. 2011 Aug;20(8):1309-18. Doi: 10.1089/scd.2010.0425. Epub 2010 Dec 27.PMID:21047210.
11. Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in Idiopathic Pulmonary Fibrosis (IPF). Antoniou KM, Papadaki HA, Soufla G, Kastrinaki MC, Damianaki A, Koutala H, Spandidos DA, Siafakas NM. Respir Med. 2010 Oct;104(10):1535-42. Doi: 10.1016/j.rmed.2010.04.015. Epub 2010 May 18. PMID: 20483575.
12. Thoracoscopic talc poudrage decreases T-lymphocytes in the peripheral blood. Froudarakis ME, Papadaki HA, Klimathianaki M, Damianaki A, Pougounias M, Kotsianidis I, Astoul P.Respir Med. 2007 Jun;101(6):1212-7. Epub 2006 Dec 19. PMID: 17182238.
13. Pro-inflammatory bone marrow milieu in patients with chronic idiopathic neutropenia is associated with impaired local production of interleukin-10. Koumaki V, Damianaki A, Ximeri M, Pontikoglou C, Axioti F, Spanoudakis M, Eliopoulos GD, Papadaki HA. Br J Haematol. 2006 Nov;135(4):570-3. Epub 2006 Oct 10. PMID: 17054669.
14. Impaired megakaryopoiesis in patients with chronic idiopathic neutropenia is associated with increased transforming growth factor beta1 production in the bone marrow. Psyllaki M, Damianaki A, Gemetzi C, Pyrovolaki K, Eliopoulos GD, Papadaki HA. Br J Haematol. 2006 Sep;134(6):624-31.PMID: 16938119.
15. Increased levels of soluble flt-3 ligand in serum and long-term bone marrow culture supernatants in patients with chronic idiopathic neutropenia. Papadaki HA, Damianaki A, Pontikoglou C, Pyrovolaki K, Eliopoulos DG, Stavroulaki E, Eliopoulos GD. Br J Haematol. 2006 Mar;132(5):637-9. PMID: 16445839.
16. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis. Papadaki HA, Tsagournisakis M, Mastorodemos V, Pontikoglou C, Damianaki A, Pyrovolaki K, Stamatopoulos K, Fassas A, Plaitakis A, Eliopoulos GD. Bone Marrow Transplant. 2005 Dec;36(12):1053-63. PMID: 16205726.
17. Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia. Papadaki HA, Stamatopoulos K, Damianaki A, Gemetzi C, Anagnostopoulos A, Papadaki T, Eliopoulos AG, Eliopoulos GD. Br J Haematol. 2005 Mar;128(6):863-76. PMID: 15755293.
18. Acute myeloid/NK precursor cell leukemia with trisomy 4 and a novel point mutation in the extracellular domain of the G-CSF receptor in a patient with chronic idiopathic neutropenia. Papadaki HA, Kosteas T, Gemetzi C, Damianaki A, Anagnou NP, Eliopoulos GD. Ann Hematol. 2004 Jun;83(6):345-8. Epub 2004 Mar 11. PMID: 15014900.
19. Increased cell apoptosis in bone marrow trephine biopsies and immunomagnetically isolated myeloid progenitor cells in patients with chronic idiopathic neutropenia. Koumaki V, Papadaki HA, Stefanaki K, Damianaki A, Gemetzi C, Katonis P, Vrentzos G, Eliopoulos GD. Ann Hematol. 2003 Oct;82(10):641-5. Epub 2003 Aug 2. PMID: 12904900.
20. Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells. Papadaki HA, Eliopoulos AG, Kosteas T, Gemetzi C, Damianaki A, Koutala H, Bux J, Eliopoulos GD. Blood. 2003 Apr 1;101(7):2591-600. Epub 2002 Nov 27. PMID: 12517813.
21. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Kampa M, Hatzoglou A, Notas G, Damianaki A, Bakogeorgou E, Gemetzi C, Kouroumalis E, Martin PM, Castanas E. Nutr Cancer. 2000;37(2):223-33. PMID: 11142097.
22. Potent inhibitory action of red wine polyphenols on human breast cancer cells. Damianaki A, Bakogeorgou E, Kampa M, Notas G, Hatzoglou A, Panagiotou S, Gemetzi C, Kouroumalis E, Martin PM, Castanas E. J Cell Biochem. 2000 Jun 6;78(3):429-41. PMID: 10861841.
23. Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors. Kampa M, Bakogeorgou E, Hatzoglou A, Damianaki A, Martin PM, Castanas E. Eur J Pharmacol. 1997 Sep 24;335(2-3):255-65. PMID: 9369381.

Ελληνική Εταιρεία Κυτταρομετρίας